USA flag logo/image

An Official Website of the United States Government

OF PARASITIC INFECTIONS".

Award Information

Agency:
Department of Health and Human Services
Branch:
N/A
Award ID:
490
Program Year/Program:
1983 / SBIR
Agency Tracking Number:
490
Solicitation Year:
N/A
Solicitation Topic Code:
N/A
Solicitation Number:
N/A
Small Business Information
Analtom Inc
1183 Bordeaux Dr #1 Sunnyvale, CA 94089
View profile »
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No
 
Phase 1
Fiscal Year: 1983
Title: OF PARASITIC INFECTIONS".
Agency: HHS
Contract: N/A
Award Amount: $51,506.00
 

Abstract:

OF PARASITIC INFECTIONS". SCHISTOSOMIASIS REMAINS ONE OF THE MOST SIGNIFICANT PARASITIC DISEASES IN THE WORLD, PARTICULARLY IN THE RURAL AGRARIAN THIRD WORLD. CURRENT DEVELOPMENT OF EXPANDED AGRICULTURAL PROGRAMS UTILIZING PERENNIAL IRRIGATION SCHEMES AND WATER IMPOUNDMENT HAVE PROMOTED THE SPREAD OF THIS DISEASE. DEVELOPMENT OF VACCINES HAS BEEN SLOW FOR THIS AND OTHER WELL-KNOWN PROTOZOAN AND HELMINTHIC INFECTIONS. A MOST PROMISING APPROACH HAS BEEN UTILIZATION OF RADIATION-ATTENUATED CERCARIAE OR SHCISTOSOMULA WHICH IS INTENDED TO STIMULATE ANTIBODY PRODUCTION IN THE HOST WITHOUT RESULTING IN A FULL-SCALE INFESTATION OR FURTHER PROPAGATION OF THE PARASITE. RESULTS TO DATE HAVE NOT BEEN DEFINITIVE ENOUGH TO JUSTIFY ADOPTION OF THIS APPROACH AS A METHOD OF PREVENTION OR CONTROL. IN PREPARING THE IRRADIATED VACCINES, LOW LINEAR ENERGY TRANSFER (LET) RADIATION (X-RAYSAND ELECTRONS) HAVE BEEN USED. WE BELIEVE A SIGNIFICANT IMPROVEMENT IN RELIABILITY OF RESULTS (STERILITY AND INHIBITION OF GROWTH ALONG WITH ADEQUATE HOST ANTIBODY PRODUCTION) CAN BE ACHIEVED BY USE OF HIGH LET RADIATION PROTONS, NEUTRONS, OR HEAVIER CHARGED PARTICLES). THE RELATIVELY HIGH MUTAGENICITY VS. KILL OF HIGH LET RADIATION HAS BEEN WELL ESTABLISHED. SHOULD THIS APPROACH PROVE CORRECT, WE BELIEVE THE PROBABILITY OF PREPARING A LONGER- LIVED VACCINE IS ENHANCED. WE ARE NOT AWARE OF ANY OTHER STUDY USING THIS APPROACH. THE PRINCIPAL INVESTIGATORS HAVEHAD EXTENSIVE EXPERIENCE IN THE APPLICATIONS OF RADIATION INGENERAL AND IN THE SPECIFIC REQUIREMENTS FOR A VACCINE. SHOULD THE RESULTS OF PHASE I PROVE POSITIVE, IT WOULD LEAD TO A PHASE II EFFORT DIRECTED TOWARD ACHIEVING ACCEPTANCE AND RELIABLE, REPRODUCIBLE PRODUCTION. THE COMMERCIAL VALUE OF IRRADIATED ORGANISM VACCINES IN VETERINARY MEDICINEHAS ALREADY BEEN WELL DEMONSTRATED. PRELIMINARY DISCUSSIONSWITH PRINCIPALS OF A MAJOR U.S. PHARMACEUTICAL ORGANIZATION INDICATES THAT THERE COULD BE SIGNIFICANT INTEREST IN DEVELOPMENT, MANUFACTURE, AND DISTRIBUTION OF THE VACCINE. THE GREATEST INTEREST WILL BE WITHIN THOSE ORGANIZATIONS WORKING WITH BIOLOGICALS. A RELIABLE, SAFE, AND LONGER LIVED VACCINE BASED ON IRRADIATED IMMATURE SCHISTOSOMES WILLBE UTILIZED EXTENSIVELY.

Principal Investigator:

Henry j. gomberg ph.d.
PRINCIPAL INVESTIGATOR
3139941200

Business Contact:

Small Business Information at Submission:

Ann Arbor Nuclear Inc.
Box 8618, 3300 Plymouth Road Ann Arbor, MI 48107

EIN/Tax ID:
DUNS: N/A
Number of Employees: N/A
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No